| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.15 | 0.3 |